FDA NDC Directory · JSON-LD · Markdown

Ranitidine

NDC 53746-254 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAmneal Pharmaceuticals of New York LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA077824
Dosage form / routeTABLET · ORAL
Active ingredientsRANITIDINE HYDROCHLORIDE (300 mg/1)
Marketing started20091216
Package count3

External sources

Source: openFDA. Public-domain (CC0).